Article Details

Lilly CFO steps down after investigation found 'inappropriate' behavior

Retrieved on: 2021-02-09 17:03:45

Tags for this article:

Click the tags to see associated articles and topics

Lilly CFO steps down after investigation found 'inappropriate' behavior. View article details on hiswai:

Excerpt

This year, the biotech spent about $27 billion trying to become a leader in cancer research. Executives who spoke to BioPharma Dive said there's still ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up